Get the Stockscreener App
10.08
2.54%
0.25
Global X Genomics Biotechnology Etf Stock (GNOM) Forecast
The Global X Genomics Biotechnology Etf (GNOM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $8.0811, representing a -19.83% decrease from the current price of $10.08. The highest analyst price target is $8.8397, and the lowest is $7.3226.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GNOM Price Target
Average 8.3517
(-17.15% Downside)
Is Global X Genomics Biotechnology Etf (GNOM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.95 | Neutral |
| STOCH(9,6) | 16.88 | Buy |
| STOCHRSI(14) | 56.10 | Neutral |
| MACD(12,26) | -0.2597 | Sell |
| ADX(14) | 24.69 | Neutral |
| William %R | -64.33 | Neutral |
| CCI(14) | -47.52 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
10.10
Sell
|
10.07
Buy
|
| MA20 |
10.37
Sell
|
10.29
Sell
|
| MA50 |
10.75
Sell
|
10.61
Sell
|
| MA100 |
10.98
Sell
|
10.78
Sell
|
| MA200 |
10.91
Sell
|
10.83
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, GNOM could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on GNOM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.95 indicates that GNOM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.88 indicates that GNOM is oversold. This indicates that GNOM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 56.1 indicates that GNOM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.69 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -47.52 indicates that GNOM is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term GNOM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Global X Genomics Biotechnology Etf financial reports and earnings history, Global X Genomics Biotechnology Etf (GNOM) stock could reach $0.432 by 2030, $13.78 by 2040 and $36.17 by 2050. See the projected annual prices until 2050 of the Global X Genomics Biotechnology Etf stock below:
- Global X Genomics Biotechnology Etf (GNOM) is expected to reach an average price of $9.8788 in 2035, with a high prediction of $10.71 and a low estimate of $10.53. This indicates an $-2.00% rise from the last recorded price of $10.08.
- Global X Genomics Biotechnology Etf (GNOM) stock is projected to chart a bullish course in 2040, with an average price target of $14.16, representing an $40.44% surge from its current level. The forecast ranges from a conservative $13.70 to a sky-high $13.78.
- Our analysts predict Global X Genomics Biotechnology Etf (GNOM) to jump 140.14% by 2045, soaring from $24.69 to an average price of $24.21, potentially reaching $25.46. While $24.69 is the low estimate, the potential upside is significant.
- Global X Genomics Biotechnology Etf (GNOM) stock is expected to climb by 2050, reaching an average of $36.87, a $265.81% jump from its current level. However, a wide range of estimates exists, with high and low targets of $36.17 and $36.22, respectively, highlighting the market's uncertainty.
Global X Genomics Biotechnology Etf Stock (GNOM) Year by Year Forecast
Global X Genomics Biotechnology Etf Stock (GNOM) Price Forecast for 2024
Our forecast for GNOM stock price in 2024 now indicates an average price target of $9.9282 with a high forecast of $12.53 and a low forecast of $7.3226. The average prediction reflects an decrease of -1.51% from the last recorded price of $10.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $7.5926 | $7.3226 | $8.8397 | -24.68% |
Global X Genomics Biotechnology Etf Stock (GNOM) Price Forecast for 2025
Global X Genomics Biotechnology Etf Stock (GNOM) is expected to reach an average price of $8.3517 in 2025, with a high prediction of $10.38 and a low estimate of $6.3232. This indicates an -17.15% fall from the last recorded price of $10.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.5009 | $6.3232 | $7.8703 | -25.59% |
| February, 2025 | $8.1472 | $6.7862 | $8.5215 | -19.17% |
| March, 2025 | $9.3621 | $7.9592 | $9.4821 | -7.12% |
| April, 2025 | $8.6904 | $8.5328 | $9.6598 | -13.79% |
| May, 2025 | $9.261 | $8.4057 | $9.391 | -8.12% |
| June, 2025 | $9.7716 | $8.9387 | $10.38 | -3.06% |
| July, 2025 | $8.4499 | $8.4099 | $9.9693 | -16.17% |
| August, 2025 | $7.9801 | $7.4826 | $8.4776 | -20.83% |
| September, 2025 | $7.1859 | $6.4806 | $8.345 | -28.71% |
| October, 2025 | $7.8225 | $6.8472 | $7.8725 | -22.40% |
| November, 2025 | $7.2237 | $7.0294 | $8.3184 | -28.34% |
| December, 2025 | $7.2003 | $7.0035 | $8.1296 | -28.57% |
Global X Genomics Biotechnology Etf Stock (GNOM) Price Forecast for 2026
The predicted value for Global X Genomics Biotechnology Etf (GNOM) in 2026 is set at an average of $6.1215. Estimates vary from a peak of $8.2265 to a trough of $4.0165, indicating an -39.27% surge from the present price of $10.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.453 | $6.7856 | $7.7197 | -26.06% |
| February, 2026 | $6.0028 | $5.9035 | $7.5218 | -40.45% |
| March, 2026 | $6.164 | $5.9931 | $6.6687 | -38.85% |
| April, 2026 | $5.0605 | $4.9105 | $6.4793 | -49.80% |
| May, 2026 | $5.2018 | $4.0165 | $5.2759 | -48.40% |
| June, 2026 | $5.8787 | $4.5024 | $6.253 | -41.68% |
| July, 2026 | $7.0977 | $5.6983 | $7.4296 | -29.59% |
| August, 2026 | $6.4908 | $6.3255 | $7.4196 | -35.61% |
| September, 2026 | $7.1374 | $6.2214 | $7.2484 | -29.19% |
| October, 2026 | $7.2086 | $7.0086 | $8.2265 | -28.49% |
| November, 2026 | $6.3498 | $6.3098 | $7.4539 | -37.01% |
| December, 2026 | $4.93 | $4.741 | $6.3852 | -51.09% |
Global X Genomics Biotechnology Etf Stock (GNOM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Global X Genomics Biotechnology Etf (GNOM) is $3.7612, with a high forecast of $5.8126 and a low forecast of $1.7097. This indicates an -62.69% decrease from the last price of $10.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.5532 | $3.9059 | $4.753 | -54.83% |
| February, 2027 | $5.2937 | $4.3108 | $5.3437 | -47.48% |
| March, 2027 | $5.3085 | $4.5313 | $5.8126 | -47.34% |
| April, 2027 | $4.7404 | $4.5436 | $5.6544 | -52.97% |
| May, 2027 | $5.0238 | $4.3334 | $5.2905 | -50.16% |
| June, 2027 | $3.8871 | $3.5048 | $5.1002 | -61.44% |
| July, 2027 | $3.809 | $3.746 | $4.293 | -62.21% |
| August, 2027 | $2.7308 | $2.5808 | $3.8219 | -72.91% |
| September, 2027 | $2.5456 | $1.7097 | $3.1784 | -74.75% |
| October, 2027 | $3.9175 | $2.2186 | $3.9845 | -61.14% |
| November, 2027 | $4.8675 | $3.6034 | $5.1994 | -51.71% |
| December, 2027 | $4.1742 | $4.1183 | $5.197 | -58.59% |
Global X Genomics Biotechnology Etf Stock (GNOM) Price Forecast for 2028
In 2028, Global X Genomics Biotechnology Etf (GNOM) is projected to reach an average price of $3.1056, with a high projection of $6.0728 and a low estimate of $0.1383. This indicates an -69.19% fall from the last price of $10.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.976 | $4.0371 | $5.087 | -50.63% |
| February, 2028 | $5.0779 | $4.8779 | $6.0728 | -49.62% |
| March, 2028 | $3.4027 | $3.2977 | $5.3309 | -66.24% |
| April, 2028 | $2.34 | $2.151 | $4.1316 | -76.79% |
| May, 2028 | $2.3231 | $1.3312 | $2.5031 | -76.95% |
| June, 2028 | $2.51 | $1.7743 | $2.9156 | -75.10% |
| July, 2028 | $2.8181 | $2.0331 | $3.3068 | -72.04% |
| August, 2028 | $2.0112 | $1.8812 | $3.1792 | -80.05% |
| September, 2028 | $2.5836 | $2.0418 | $2.8612 | -74.37% |
| October, 2028 | $1.4961 | $1.1062 | $2.5443 | -85.16% |
| November, 2028 | $0.7692 | $0.7492 | $1.9174 | -92.37% |
| December, 2028 | $0.1183 | $0.1383 | $0.8998 | -98.83% |
Global X Genomics Biotechnology Etf Stock (GNOM) Price Forecast for 2029
The 2029 price forecast for Global X Genomics Biotechnology Etf Stock (GNOM) is $1.9617 on average, with a high prediction of $3.9191 and a low estimate of $0.00418. This represents an -80.54% decrease from the previous price of $10.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1848 | $0.00418 | $1.1848 | -88.25% |
| February, 2029 | $1.5673 | $1.1767 | $1.9673 | -84.45% |
| March, 2029 | $2.4298 | $1.3579 | $2.9745 | -75.90% |
| April, 2029 | $1.9822 | $1.911 | $2.8687 | -80.33% |
| May, 2029 | $3.3653 | $1.8529 | $3.9191 | -66.61% |
| June, 2029 | $2.8278 | $2.7378 | $3.856 | -71.95% |
| July, 2029 | $1.3103 | $1.2053 | $3.0184 | -87.00% |
| August, 2029 | $0.9615 | $0.439 | $2.0622 | -90.46% |
| September, 2029 | $0.2286 | $0.7286 | $0.6514 | -97.73% |
| October, 2029 | $0.1678 | $0.1055 | $0.5528 | -98.34% |
| November, 2029 | $0.2854 | $0.2212 | $0.801 | -97.17% |
| December, 2029 | $0.441 | $0.2541 | $0.704 | -95.62% |
Global X Genomics Biotechnology Etf Stock (GNOM) Price Forecast for 2030
Global X Genomics Biotechnology Etf Stock (GNOM) is expected to reach an average price of $1.5018 in 2030, with a high forecast of $2.9941 and a low forecast of $0.00961. This signifies an -85.10% decrease from the last price of $10.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3997 | $0.0416 | $0.432 | -96.04% |
| February, 2030 | $0.6866 | $0.8314 | $0.7948 | -93.19% |
| March, 2030 | $1.5835 | $0.5883 | $0.8835 | -84.29% |
| April, 2030 | $2.4404 | $1.7052 | $1.6904 | -75.79% |
| May, 2030 | $1.099 | $2.2873 | $2.6183 | -89.10% |
| June, 2030 | $0.6859 | $0.6859 | $0.7207 | -93.20% |
| July, 2030 | $0.2655 | $0.0555 | $0.7519 | -97.37% |
| August, 2030 | $0.1314 | $0.138 | $0.2804 | -98.70% |
| September, 2030 | $1.2117 | $0.0348 | $1.7655 | -87.98% |
| October, 2030 | $0.8031 | $0.5531 | $1.71 | -92.03% |
| November, 2030 | $0.6238 | $0.00961 | $0.8813 | -93.81% |
| December, 2030 | $3.5439 | $0.4973 | $2.9941 | -64.84% |
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):